Labor and Delivery Practice Questions

Q: What is the risk of scar rupture in a previous lower segment cesarean section (LSCS)?

1%. **Explanation:** The risk of uterine scar rupture is a critical consideration when planning a Trial of Labor After Cesarean (TOLAC). For a patient with one previous **Lower Segment Cesarean Section (LSCS)**, the risk of rupture is approximately **0.5% to 1%**. **1. Why Option A is Correct:** The lower uterine segment is relatively thin and contains less muscular tissue compared to the upper segment. During a previous LSCS, the transverse incision heals well and is subjected to less tension during subsequent labor contractions. Large-scale clinical studies (such as those by ACOG and RCOG) consistently cite the risk of rupture for a single low-transverse scar at roughly 0.7–0.9%, making **1%** the most accurate representative figure for exams. **2. Why Other Options are Incorrect:** * **Option B (5%):** This is too high for a standard LSCS. However, the risk increases to approximately 2–3% if the patient has two previous LSCS scars. * **Option C (10%):** This range is associated with a **Classical Cesarean Section** scar (vertical incision in the upper segment), where the risk is significantly higher (4–9%) due to the thick, active muscular involvement of the fundus. * **Option D (50%):** This is clinically inaccurate and would make TOLAC an absolute contraindication in all scenarios. **High-Yield Clinical Pearls for NEET-PG:** * **Most common sign of scar rupture:** Fetal heart rate abnormalities (typically prolonged bradycardia). * **Most specific sign:** Recession of the presenting part (Station goes from +1 to -3). * **Classical Scar:** Risk of rupture is 4–9% and can occur *before* the onset of labor. * **LSCS Scar:** Risk is <1% and usually occurs *during* the active phase of labor. * **Contraindication for TOLAC:** Previous classical/T-shaped incision, previous uterine rupture, or any contraindication to vaginal delivery (e.g., placenta previa).

Q: Combination of Nifedipine with what other tocolytic agent can potentially cause dangerous neuromuscular blockade?

Magnesium sulfate. ### Explanation The correct answer is **Magnesium sulfate (MgSO₄)**. **Mechanism of Interaction:** Both Nifedipine (a Calcium Channel Blocker) and Magnesium sulfate act by inhibiting calcium-related processes, but at different sites. Nifedipine blocks the entry of extracellular calcium into the myometrial cells through L-type channels. Magnesium sulfate competes with calcium at the neuromuscular junction and inhibits the release of acetylcholine. When used together, they exert a synergistic effect that can lead to profound muscle relaxation, resulting in **dangerous neuromuscular blockade**, respiratory depression, and cardiac toxicity. **Analysis of Incorrect Options:** * **A. Terbutaline:** This is a $\beta_2$-agonist. While combining it with Nifedipine can increase the risk of maternal pulmonary edema and tachycardia, it does not cause neuromuscular blockade. * **C. Indomethacin:** A COX inhibitor used as a second-line tocolytic (especially before 32 weeks). Its primary side effects are fetal (premature closure of ductus arteriosus and oligohydramnios), not neuromuscular. * **D. Atosiban:** An oxytocin receptor antagonist. It has a very specific site of action and a superior safety profile; it does not interact with Nifedipine to cause muscle paralysis. **High-Yield Clinical Pearls for NEET-PG:** * **First-line Tocolytic:** Nifedipine is currently the preferred first-line tocolytic for preterm labor (32–34 weeks) due to its oral administration and better side-effect profile. * **Antidote for MgSO₄ Toxicity:** Calcium gluconate (10 ml of 10% solution IV over 10 minutes). * **Contraindication:** Nifedipine should be avoided in patients with hypotension or cardiac disease. * **Monitoring:** When a patient is on MgSO₄, always monitor the **patellar reflex** (first sign of toxicity to disappear), respiratory rate (>12/min), and urine output (>30ml/hr).

Q: What does the indicator in the following partograph signify?

Moderate uterine contractions. ***Moderate uterine contractions*** - **Hatched/lined shading** on the partograph indicates moderate uterine contractions lasting **20-40 seconds** in duration. - This represents the **standard method** for documenting contraction intensity using visual indicators on labor monitoring charts. *Mild uterine contractions* - Represented by **dotted shading** on the partograph, indicating contractions lasting **less than 20 seconds**. - These are typically **weaker contractions** that occur early in labor or during latent phase. *Strong uterine contractions* - Indicated by **solid black shading** on the partograph for contractions lasting **more than 40 seconds**. - These represent **intense contractions** typically seen during active labor and transition phases. *Arrest of labor* - This is a **clinical diagnosis** based on lack of cervical dilation or fetal descent, not a partograph shading indicator. - Would be identified by **plotting cervical dilation** crossing the action line, not by contraction shading patterns.

Q: Prolonged latent phase of labor is commonly seen in which of the following conditions?

Unripe cervix. The **Latent Phase** of labor begins with the onset of regular uterine contractions and ends when the cervix reaches 4–6 cm dilation. According to Friedman’s criteria, a prolonged latent phase is defined as **>20 hours in primigravida** and **>14 hours in multigravida**. ### Why "Unripe Cervix" is Correct: The primary physiological goal of the latent phase is **cervical effacement** and softening. An **unripe cervix** (low Bishop score) presents high resistance to uterine contractions. This lack of readiness necessitates a longer period of contractions to achieve the structural changes required for active dilation, making it the most common cause of a prolonged latent phase. ### Analysis of Incorrect Options: * **Excessive Sedation:** While early administration of analgesics or sedatives can slow down labor, it is a secondary factor. An unripe cervix remains the most frequent clinical finding associated with this delay. * **Placenta Previa:** This is a condition where the placenta covers the internal os. It is a contraindication to vaginal delivery and typically presents with painless antepartum hemorrhage, not a delay in the latent phase. * **Abruptio Placenta:** This involves premature separation of the placenta. It often leads to uterine hypertonicity and rapid (precipitate) labor or fetal distress, rather than a prolonged latent phase. ### High-Yield NEET-PG Pearls: * **Management:** The preferred management for a prolonged latent phase is **therapeutic rest** (e.g., Morphine) or **oxytocin augmentation**. It is *not* an indication for Cesarean section. * **Friedman vs. WHO:** While Friedman used 4 cm as the start of the active phase, the **WHO Labor Care Guide (2020)** now defines the active phase starting at **5 cm** dilation. * **Most common cause overall:** Unripe cervix at the onset of labor.

Q: Prelabour pains are mediated through which spinal nerve roots?

T10-T12. **Explanation:** The pain experienced during the first stage of labor (including prelabour or "false" pains) is primarily **visceral** in nature. It originates from the stretching of the lower uterine segment and the dilation of the cervix. 1. **Why T10–T12 is correct:** The sensory nerve fibers from the body of the uterus and the cervix travel alongside sympathetic nerves. They pass through the hypogastric plexus and enter the spinal cord via the **T10, T11, and T12** (and occasionally L1) spinal nerve roots. Therefore, pain during the early stages of labor is referred to the dermatomes supplied by these segments (the lower abdomen and lumbar region). 2. **Analysis of Incorrect Options:** * **T12–L3:** While there is some overlap at T12 and L1, the primary sensory input for uterine contractions does not extend down to L3. * **S2–S4 (Option C/S1-S3):** These roots mediate **somatic pain** during the **second stage of labor**. This pain is caused by the stretching of the pelvic floor, vagina, and perineum as the fetus descends, transmitted via the **pudendal nerve**. * **L3–L4:** These segments are generally not involved in the primary pain pathways for labor; they are more relevant for lower limb motor and sensory functions. **High-Yield Clinical Pearls for NEET-PG:** * **First Stage of Labor:** Pain is visceral, mediated by **T10–L1**. * **Second Stage of Labor:** Pain is both visceral (uterus) and somatic (perineum), mediated by **T10–L1 AND S2–S4**. * **Epidural Anesthesia:** To provide effective relief during the first stage, the block must reach the **T10** level. * **Paracervical Block:** Targets the Frankenhäuser’s plexus to relieve pain from cervical dilation (Stage 1) but does not relieve perineal pain (Stage 2).

Q: Which of the following is a contraindication for the use of ergometrine?

Heart disease. **Explanation:** Ergometrine (an ergot alkaloid) is a potent uterotonic used to prevent and treat postpartum hemorrhage (PPH). Its primary mechanism involves inducing tetanic uterine contractions and causing generalized **vasoconstriction**. **Why Heart Disease is the Correct Answer:** Ergometrine causes significant peripheral vasoconstriction and a sudden rise in blood pressure. This leads to a rapid increase in venous return (preload), which can overload a compromised heart, potentially triggering **acute heart failure, pulmonary edema, or arrhythmias**. It is also contraindicated in patients with severe hypertension and pre-eclampsia for the same reason. **Analysis of Incorrect Options:** * **A. Diabetes Mellitus:** There is no direct contraindication for ergometrine in diabetic patients, as it does not acutely interfere with glycemic control or insulin sensitivity. * **B. Excessive Post-partum Hemorrhage:** This is actually an **indication** for ergometrine. It is a second-line agent (after Oxytocin) used to manage atonic PPH due to its rapid and sustained contractile effect. * **C. Anaemia:** Anaemia is not a contraindication. In fact, preventing blood loss with uterotonics is crucial in anaemic patients who have low physiological reserves. **High-Yield Clinical Pearls for NEET-PG:** * **Route & Dose:** Usually 0.2 mg IM/IV. IV must be given very slowly. * **Side Effects:** Nausea, vomiting (most common), and transient hypertension. * **Storage:** It is light-sensitive and must be stored in a refrigerator (2–8°C). * **Contraindications Summary:** Heart disease, Hypertension (BP >140/90), Pre-eclampsia/Eclampsia, and Peripheral Vascular Disease (Raynaud’s). * **Active Management of Third Stage of Labor (AMTSL):** While Oxytocin is the drug of choice, Syntometrine (a combination of Oxytocin and Ergometrine) is sometimes used but carries the same cardiac risks.

Q: Which of the following drugs is not used for induction of labor?

Betamethasone. **Explanation:** The correct answer is **Betamethasone**. Induction of labor (IOL) refers to the artificial stimulation of uterine contractions before the onset of spontaneous labor to achieve vaginal delivery. **Why Betamethasone is the correct answer:** Betamethasone is a corticosteroid used in obstetrics for **Antenatal Corticosteroid Therapy (ACT)**. Its primary role is to accelerate fetal lung maturity by stimulating surfactant production in pregnancies at risk of preterm delivery (between 24 and 34 weeks). It has no role in inducing uterine contractions or cervical ripening. **Why the other options are used for induction:** * **Prostaglandin E2 (Dinoprostone):** This is the gold standard for cervical ripening. It acts by breaking down collagen and increasing submucosal water content in the cervix. It is available as intracervical gels or sustained-release vaginal inserts. * **Prostaglandin E1 (Misoprostol):** A synthetic PGE1 analogue. While originally used for peptic ulcers, it is highly effective for both cervical ripening and labor induction. It is administered vaginally or orally (25 mcg for IOL). * **Mifepristone (RU-486):** An anti-progestogen. By blocking progesterone receptors, it increases the sensitivity of the myometrium to prostaglandins and helps in cervical softening. It is often used for IOL in cases of intrauterine fetal death (IUFD). **High-Yield Clinical Pearls for NEET-PG:** * **Bishop Score:** Used to assess "inducibility." A score of $\geq$ 8 suggests a high likelihood of successful vaginal delivery. * **Oxytocin:** The drug of choice for induction when the cervix is already "favorable" (high Bishop score). * **Contraindication for Misoprostol:** It should **not** be used for induction in women with a previous Cesarean section due to the high risk of uterine rupture. * **Betamethasone Dosage:** 12 mg IM, two doses 24 hours apart.

Q: Hematuria during labor in a patient with a previous cesarean section is a sign of:

Impending rupture of scar. **Explanation:** **Correct Answer: A. Impending rupture of scar** In a patient with a previous cesarean section, the bladder is often densely adherent to the lower uterine segment (LUS) due to postoperative adhesions. As the scar thins out and begins to give way (impending rupture), the stretching and shearing forces are transmitted to the posterior wall of the bladder. This leads to mucosal congestion and capillary rupture, manifesting as **hematuria**. In the context of a scarred uterus, hematuria is considered a "warning sign" of uterine dehiscence or rupture and warrants immediate evaluation. **Analysis of Incorrect Options:** * **B. Urethral trauma:** While trauma can cause hematuria, it usually occurs during instrumental delivery (forceps/vacuum) or difficult catheterization, rather than as a spontaneous sign during the course of labor. * **C. Prolonged labor:** Prolonged labor may lead to the formation of a Bandl’s ring or pressure necrosis (potentially causing fistulas later), but hematuria specifically in a post-CS patient is a classic indicator of scar instability. * **D. Sepsis:** Sepsis presents with systemic signs like fever, tachycardia, and foul-smelling liquor. While it can cause multi-organ dysfunction, it is not a primary cause of isolated hematuria during labor. **NEET-PG High-Yield Pearls:** * **Scar Rupture Signs:** The most common sign of uterine rupture is an **abnormal FHR pattern** (usually fetal bradycardia). Other signs include loss of station of the presenting part, cessation of contractions, and maternal tachycardia/shock. * **Scar Tenderness:** Persistent localized tenderness over the lower uterine segment between contractions is a significant clinical sign of impending rupture. * **Management:** If scar rupture is suspected, the immediate step is an emergency laparotomy and delivery of the fetus.

Q: What is the WHO recommended dose of misoprostol in the treatment of postpartum hemorrhage?

800 mcg sublingual. **Explanation:** Postpartum Hemorrhage (PPH) is a leading cause of maternal mortality, and its management follows specific WHO guidelines. While **Oxytocin** (10 IU IV/IM) remains the first-line drug for both prevention and treatment, **Misoprostol** (a Prostaglandin E1 analogue) is a critical alternative, especially in low-resource settings. **Why Option C is correct:** According to the WHO recommendations for the **treatment** of PPH, the recommended dose of Misoprostol is **800 mcg sublingual**. The sublingual route is preferred for treatment because it achieves the highest peak plasma concentration and the fastest onset of action (approximately 11 minutes), which is vital in an emergency hemorrhagic state. **Analysis of Incorrect Options:** * **A & B (400 mcg / 600 mcg):** These doses are used for the **prevention** (prophylaxis) of PPH, not treatment. The WHO recommends 600 mcg orally for prevention in settings where oxytocin is unavailable. * **D (1000 mcg):** While older protocols occasionally mentioned higher doses (often rectal), current WHO guidelines cap the therapeutic dose at 800 mcg to balance efficacy against side effects like shivering and pyrexia. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for PPH Prophylaxis:** Oxytocin (10 IU IM/IV). * **DOC for PPH Treatment:** Oxytocin (IV infusion) + Ergometrine (if no hypertension) or Carboprost (PGF2α). * **Misoprostol Side Effects:** Shivering and transient fever (pyrexia) are very common. * **Contraindication:** Avoid Ergometrine and Carboprost in patients with hypertension and asthma, respectively. Misoprostol is generally safe in these conditions.

Question 1

What is the risk of scar rupture in a previous lower segment cesarean section (LSCS)?

Accepted Answer

1%

Answer

5%

Answer

10%

Answer

50%

Question 2

In which of the following patients can a midline episiotomy be considered superior to a mediolateral episiotomy during delivery of the fetus?

Accepted Answer

Second gravida with moderate anemia

Answer

Nulligravida with a thick perineum

Answer

Second stage arrest

Answer

Before the application of forceps

Question 3

Combination of Nifedipine with what other tocolytic agent can potentially cause dangerous neuromuscular blockade?

Accepted Answer

Magnesium sulfate

Answer

Terbutaline

Answer

Indomethacin

Answer

Atosiban

Question 4

What does the indicator in the following partograph signify?

Accepted Answer

Moderate uterine contractions

Answer

Mild uterine contractions

Answer

Strong uterine contractions

Answer

Arrest of labor

Question 5

Prolonged latent phase of labor is commonly seen in which of the following conditions?

Accepted Answer

Unripe cervix

Answer

Placenta previa

Answer

Abruptio placenta

Answer

Excessive sedation

Question 6

Prelabour pains are mediated through which spinal nerve roots?

Accepted Answer

T10-T12

Answer

T12-L3

Answer

S1-S3

Answer

L3-L4

Question 7

Which of the following is a contraindication for the use of ergometrine?

Accepted Answer

Heart disease

Answer

Diabetes mellitus

Answer

Excessive post-partum hemorrhage

Answer

Anaemia

Question 8

Which of the following drugs is not used for induction of labor?

Accepted Answer

Betamethasone

Answer

Prostaglandin E2 (PGE2)

Answer

Prostaglandin E1 (PGE1)

Answer

Mifepristone

Question 9

Hematuria during labor in a patient with a previous cesarean section is a sign of:

Accepted Answer

Impending rupture of scar

Answer

Urethral trauma

Answer

Prolonged labor

Answer

Sepsis

Question 10

What is the WHO recommended dose of misoprostol in the treatment of postpartum hemorrhage?

Accepted Answer

800 mcg sublingual

Answer

400 mcg oral

Answer

600 mcg sublingual

Answer

1000 mcg oral

Labor and Delivery — MCQs

Labor and Delivery — MCQs

On this page

Practice by Chapter

Want unlimited practice?